Embecta Corp Operating Income Over Time
| EMBC Stock | USD 9.79 0.20 2.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Embecta Corp Performance and Embecta Corp Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Embecta diversify its offerings? Factors like these will boost the valuation of Embecta Corp. Projected growth potential of Embecta fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Embecta Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.827 | Dividend Share 0.6 | Earnings Share 2.36 | Revenue Per Share | Quarterly Revenue Growth (0) |
Embecta Corp's market price often diverges from its book value, the accounting figure shown on Embecta's balance sheet. Smart investors calculate Embecta Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Embecta Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Embecta Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Embecta Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Embecta Corp and related stocks such as CareDx Inc, SIGA Technologies, and Emergent Biosolutions Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDNA | (2.3 M) | (2.3 M) | (2.3 M) | (857 K) | 1.2 M | (11.9 M) | (37.3 M) | (20.3 M) | (15.6 M) | (24.5 M) | (22.5 M) | (29.7 M) | (77.2 M) | (203.4 M) | 40.8 M | (21 M) | (22.1 M) |
| SIGA | (1.4 M) | (31.4 M) | (22.5 M) | (23.5 M) | (209.7 M) | (31 M) | (31 M) | (18.8 M) | 355.1 M | (2.3 M) | 84.5 M | 89.1 M | 42.7 M | 83.6 M | 70 M | 80.5 M | 84.5 M |
| EBS | (364 K) | 32.1 M | 36.6 M | 42.8 M | 89.2 M | 141.5 M | 105.5 M | 124.3 M | 89.8 M | 114.1 M | 438.5 M | 341.4 M | (166 M) | (726.4 M) | (108.7 M) | 100.1 M | 105.1 M |
| AQST | (7.8 M) | (847 K) | (847 K) | (847 K) | (847 K) | (847 K) | (847 K) | (113 K) | (48.9 M) | (52.7 M) | (42.9 M) | (34.7 M) | (42.1 M) | (15.1 M) | (30.8 M) | (27.7 M) | (29.1 M) |
| MYGN | (8.9 M) | 157.8 M | 180.3 M | 228 M | 274.4 M | 134.2 M | 166.8 M | 49.4 M | 118.7 M | 7.6 M | (194.8 M) | (190.5 M) | (140.6 M) | (257.4 M) | (123.5 M) | (139.3 M) | (132.3 M) |
| VIR | (81.5 M) | (81.5 M) | (81.5 M) | (81.5 M) | (81.5 M) | (81.5 M) | (81.5 M) | (81.5 M) | (118.7 M) | (178 M) | (297 M) | 420.8 M | 833.1 M | (684.3 M) | (587.2 M) | (468 M) | (444.6 M) |
| EVH | (19.6 M) | (19.6 M) | (19.6 M) | (21.2 M) | (25.2 M) | (43 M) | (237.4 M) | (72.8 M) | (47.5 M) | (308.9 M) | (262.8 M) | (42.4 M) | 3.6 M | (71.2 M) | (40.5 M) | (4.4 M) | (4.7 M) |
| MRVI | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 24 M | 119.9 M | 554.6 M | 574.2 M | (31.6 M) | (235.6 M) | (128.5 M) | (122.1 M) |
| PSNL | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (13.8 M) | (22.4 M) | (42.1 M) | (65.4 M) | (115.5 M) | (109.9 M) | (68.3 M) | (88.1 M) | (92.5 M) |
Embecta Corp and related stocks such as CareDx Inc, SIGA Technologies, and Emergent Biosolutions Operating Income description
Operating Income is the amount of profit realized from Embecta Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Embecta Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Embecta Corp | EMBC |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 300 Kimball Drive, |
| Exchange | NASDAQ Exchange |
USD 9.79
Check out Embecta Corp Performance and Embecta Corp Correlation. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Embecta Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.